Interim influenza vaccine effectiveness for the 2025 to 2026 season appears to be lower than in recent influenza seasons, but still provides protection for children and adolescents and for adults, ...
The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...
Inside the rigorous, step-by-step process the CDC uses to create pandemic-ready flu vaccine viruses, long before the next global health emergency strikes. Study: Development of pre-pandemic influenza ...
Vaccine effectiveness was 38% to 41% against influenza outpatient visits, 41% against flu-linked hospitalization for children younger than 18 years. (HealthDay News) — Interim influenza vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results